Article Details
Retrieved on: 2018-04-25 17:23:52
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Pharma is responding to the threat of disruption through buying expertise (Roche's acquisition of <b>Flatiron Health</b> in February) and by looking outside the usual talent pool for a more consumer and technology-focused approach. Joe Jimenez, who stepped down as CEO of Novartis in February, has a ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here